Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
111 Leser
Artikel bewerten:
(0)

Strategies in the Global Hemostasis Diagnostic Testing Market 2015 - Comparison of Analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and Other Suppliers.


DUBLIN, Aug. 13, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/vf8cwd/2015_strategies) has announced the addition of the "2015 Strategies in the Global Hemostasis Diagnostic Testing Market" report to their offering.

This comprehensive seven-country report contains 650 pages, 150 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global coagulation testing market during the next five years.

The report explores business and technological trends in the US, Europe (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Rationale


The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the global coagulation diagnostics practice during the next five years.

New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.

Sales and Market Share Analysis

  • Sales and market shares of major instrument and reagent suppliers.

Market Segmentation Analysis

Comprehensive market segmentation analysis, including:

  • Hospitals
  • Commercial/Private Laboratories
  • Physician Offices
  • Ambulatory Care Centers

Current and Emerging Products

  • Review of established and emerging procedures.
  • Comparison of automated and semi-automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.

Technology Review

  • Analysis of current and emerging technologies and their potential market applications.
  • Comprehensive lists of companies developing or marketing new technologies and products by test.
  • Worldwide Market Overview

Strategic Recommendations

  • Product development and business expansion opportunities with significant market appeal.
  • Ideal product models with tentative prices and operating characteristics.
  • Alternative market penetration strategies for instrument and reagent suppliers.

For more information visit http://www.researchandmarkets.com/research/vf8cwd/2015_strategies

Media Contact:Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.